Latest 10-Q quarterly reports

Arrow Electronics announces a significant 39% year-over-year sales increase in Q1 2026, driven by robust demand in both Global Components and Global ECS segments, particularly from AI-related growth.

Tripadvisor reports a 4% revenue decrease in Q1 2026 compared to Q1 2025, driven by a decline in the Hotels and Other segment, while Experiences segment revenue saw an 8% increase.

Amylyx Pharmaceuticals reports increased R&D spending and a net loss for Q1 2026, with cash reserves projected to last into 2028.

Foghorn Therapeutics reports Q1 2026 results with increased cash reserves, reduced operating expenses, and ongoing development in its oncology pipeline.

Papa John's reports a 7.7% revenue decrease in Q1 2026, driven by strategic transformation initiatives and a challenging consumer environment, though international sales show growth.

Vanda Pharmaceuticals reported a 3% increase in total revenues for Q1 2026, driven by strong Fanapt sales, while net loss widened due to increased SG&A expenses and lower R&D spending.

Chicago Atlantic Real Estate Finance reports a decrease in net income for Q1 2026 compared to Q1 2025, primarily due to a significant increase in the provision for expected credit losses.

U.S. Energy Corp. reports a net loss for Q1 2026, driven by lower oil and gas production, while advancing its industrial gas development, particularly the Big Sky Carbon Hub.

ARKO Corp. reported a decrease in total revenues for Q1 2026 compared to the prior year, driven by lower merchandise and fuel sales, but saw an improvement in operating income and Adjusted EBITDA.

Core Natural Resources, Inc. reported a net income of $21.04 million for the first quarter of 2026, a significant turnaround from a net loss of $69.28 million in the same period last year.

NewAmsterdam Pharma reports Q1 2026 results with ongoing clinical trials for obicetrapib, a potential LDL-C lowering therapy, and European regulatory reviews progressing.

Insmed Incorporated announced a significant increase in total product revenues for the first quarter of 2026, primarily driven by the successful launch of Brensubri in the US, alongside continued growth in ARIKAYCE international sales.

Rockwell Medical, Inc. reported a net sales decrease of 8% for the first quarter of 2026 compared to the prior year, primarily driven by reduced sales to DaVita.

Apellis Pharmaceuticals announced strong Q1 2026 revenue growth driven by its key drugs, SYFOVRE and EMPAVELI, while progressing towards its acquisition by Biogen.

Shattuck Labs, Inc. filed its Q1 2026 10-Q, detailing a net loss of $14.8 million and continued progress in its SL-325 clinical trial, with cash reserves projected to fund operations into 2029.

Tapestry, Inc. announced a significant increase in net sales and operating income for the third quarter of fiscal 2026, primarily driven by strong performance from its Coach brand.

Nuvalent, Inc. reported its first-quarter 2026 financial results, highlighting continued progress in its clinical-stage biopharmaceutical pipeline with key regulatory milestones and trial updates.

SolarEdge Technologies, Inc. announced its first quarter 2026 financial results, showing a significant 41.5% increase in revenue driven by strong battery and power optimizer sales, alongside improved gross margins.

Enovis Corporation reported a net loss of $8.45 million for the first quarter of 2026, a significant improvement from the prior year's loss, driven by increased net sales and improved gross profit margins.

ESAB Corporation reported a 9.9% increase in net sales for Q1 2026, driven by acquisitions and favorable foreign exchange, though net income from continuing operations declined due to increased expenses and acquisition-related charges.

22nd Century Group reported a 31.1% decrease in net revenues for Q1 2026 compared to the prior year, primarily due to a strategic shift away from low-priced contract manufacturing export customers.

Cognex Corporation announced its first quarter 2026 financial results, showcasing a significant 24% year-over-year revenue increase driven by broad-based demand across its key end markets.

Trulieve Cannabis Corp. reports a decrease in revenue for Q1 2026 compared to Q1 2025, primarily due to retail price compression, while Adjusted EBITDA shows a slight decline.

SoFi Technologies announced a 43% year-over-year increase in total net revenue to $1.1 billion for the first quarter of 2026, driven by robust performance across its Lending and Financial Services segments.

Blackstone Secured Lending Fund reported a decrease in investment income and a rise in interest expenses for Q1 2026, alongside a significant increase in unrealized losses.

Zai Lab Limited announced its first quarter 2026 financial results, reporting a 6% decrease in total revenues to $99.6 million, primarily driven by lower product sales.

Amcor PLC's Q3 2026 results show significant revenue and profit growth, largely attributed to the successful integration of Berry Global Group, Inc.

Arhaus, Inc. reported a modest 0.9% increase in net revenue for Q1 2026, reaching $314.3 million, but net income saw a significant decrease to $2.2 million from $4.9 million in the prior year period.

Citizens Financial Services, Inc. reported a significant increase in net income for the first quarter of 2026, driven by robust growth in net interest income.

Walker & Dunlop reported a significant increase in net income for Q1 2026, driven by a substantial rise in transaction volumes across its Capital Markets segment.